REIMBURSEMENT & MARKET ACCESS STRATEGY
An expanded universe of stakeholders–including payers, policy makers, physicians, and patients–all share in the responsibility for defining the clinical, economic, and societal value of today’s revolutionary new treatments. Accordingly, our team works with clients on reimbursement and market access strategy to provide a better understanding of the current and future landscape in order to better align, support, and demonstrate evidence of product value to ensure commercial adoption and excellence.
We offer a range of services to support reimbursement and market access strategy decisions, from payer segmentation analysis to coverage and access trends
Payer Segmentation Analysis
Pre-Launch and Post-Launch Reimbursement Strategy
Payer and Organized Provider Value Proposition Development and Testing
Value Message Framework Construction
Competitive Simulation Workshops
Coverage and Access Trends
A public biopharma company had a novel pre-commercial therapeutic to treat diseases of the eye and recognized that the construction of payer coverage policies would be a critical factor in determining access to their product.